GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Vldlr | increases expression | ISO | VLDLR (Homo sapiens) | 6480464 | CTD | Tunicamycin results in increased expression of VLDLR mRNA; Tunicamycin results in increased expression of VLDLR protein | PMID:29289645 | Vldlr | increases expression | ISO | Vldlr (Mus musculus) | 6480464 | CTD | Tunicamycin results in increased expression of VLDLR mRNA; Tunicamycin results in increased expression of VLDLR protein | PMID:29289645 | Vldlr | multiple interactions | ISO | VLDLR (Homo sapiens) | 6480464 | CTD | FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein] | PMID:29289645 | Vldlr | multiple interactions | ISO | Vldlr (Mus musculus) | 6480464 | CTD | [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of VLDLR mRNA; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR protein] | PMID:29289645 | |
Go Back to source page | Continue to Ontology report |